The race is on. Microsoft and Google have launched their respective electronic medical record (EMR) programs, and it’s going to be interesting to see which tech giant will get the edge on the platform.
In the last week, both camps announced partnerships with some pretty big names in the EMR worlds. Microsoft has teamed up with […]

[Read more →]

If, in the wake of the sale of Millennium, you’ve been wondering what ever happened to the company’s co-founder and longtime CEO Mark Levin, the answer was in this morning’s deal news, in the announcement that a young biotech called Constellation Pharmaceuticals had closed a $32 million Series A financing. The companies coming up with […]

[Read more →]

I had a chance late last week to moderate a panel at the Healthcare Dealmaking Symposium, sponsored by our friends at The Deal. My panelists, Annarie Lyles, SVP and Head of Corporate Development for Genmab, and Robert Knowles, Senior Director of Worldwide Business Development for Pfizer, had some very interesting insights into the state of […]

[Read more →]

We didn’t get to travel to this year’s JPMorgan Healthcare Conference, but Pharm Exec contributor Audrey S. Erbes (founder of Erbes & Associates) did. Here are her impressions:
There was a lack of usual excitement among drug companies but no sense of distress.
Although this year’s event broke attendance records with more than 7,700 participants and 331 […]

[Read more →]